WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals International PLC Stock Ownership - Who owns Kiniksa Pharmaceuticals International?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kiniksa Pharmaceuticals International PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael R. MegnaCAO2026-09-034,600$80.30
$369.38kSell
Michael R. MegnaCAO2026-09-015,531$79.28
$438.50kSell
Ross MoatCOO2026-09-014,007$79.28
$317.67kSell
Sanj K. PatelCEO;Chair2026-09-0115,144$79.28
$1.20MSell
Sanj K. PatelCEO;Chair2026-09-0115,144$79.28
$1.20MSell
John F. PaoliniMed2026-09-014,029$79.28
$319.42kSell
Mark RagosaCFO2026-09-014,404$79.28
$349.15kSell
G. Bradley ColeDirector2026-07-293,673$81.43
$299.09kSell
Michael R. MegnaCAO2026-07-15279$33.50
$9.35kBuy
Sanj K. PatelCHAIRMAN CEO2026-05-0148,565$54.02
$2.62MSell

1 of 12

KNSA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KNSA insiders and whales buy or sell their stock.

KNSA Shareholders

What type of owners hold Kiniksa Pharmaceuticals International PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP3.54%2,759,734$207.20MInsider
Cormorant Asset Management LP2.22%1,731,442$130.00MInsider
Sanj K. Patel2.00%1,560,451$117.16MInsider
James E. Flynn1.57%1,226,890$92.11MInsider
Thomas W. Beetham0.38%297,523$22.34MInsider
Stephen F. Mahoney0.15%116,187$8.72MInsider
Thomas Malley0.11%87,312$6.56MInsider
Carsten Boess0.10%79,589$5.98MInsider
Chris Heberlig0.10%79,589$5.98MInsider
John F. Paolini0.09%69,922$5.25MInsider

1 of 3

KNSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KNSA0.06%10.48%Net SellingNet Selling
MIRM0.11%81.26%Net BuyingNet Selling
SRRK0.11%67.31%Net BuyingNet Selling
CGON0.11%16.34%Net BuyingNet Buying
LGND0.02%99.98%Net SellingNet Selling
View Top Biotech Stocks

Kiniksa Pharmaceuticals International Stock Ownership FAQ

Who owns Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) is owned by 0.06% institutional shareholders, 10.48% Kiniksa Pharmaceuticals International insiders, and 89.46% retail investors. Baker Bros Advisors LP is the largest individual Kiniksa Pharmaceuticals International shareholder, owning 2.76M shares representing 3.54% of the company. Baker Bros Advisors LP's Kiniksa Pharmaceuticals International shares are currently valued at $207.20M.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals International stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.